We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
201
Nebius Group N.V.
NBIS
$56.4B
| $5.49M | 0.09% |
153,897
+71,251
| +86% | +$2.19M |
|
|
AMRN
202
Amarin Corp
AMRN
$294M
| $5.46M | 0.08% |
155,059
-6,803
| -4% | -$213K |
|
|
ICEL
203
DELISTED
CELLULAR DYNAMICS INTL INC COM STK (WI)
ICEL
| $5.46M | 0.08% |
374,600
+64,300
| +21% | +$813K |
|
|
HCT
204
DELISTED
AMRICAN RLTY CAP HEALTHCARE TRUST INC. COMMON STOCK
HCT
| $5.44M | 0.08% |
+499,757
| New | +$5.18M |
|
|
AET
205
DELISTED
Aetna Inc
AET
| $5.42M | 0.08% |
66,901
-887
| -1% | -$67.1K |
|
206
Curtiss-Wright
CW
$20.8B
| $5.42M | 0.08% |
+82,720
| New | +$5.43M |
|
|
MW
207
DELISTED
THE MENS WAREHOUSE INC
MW
| $5.36M | 0.08% |
96,006
+54,412
| +131% | +$2.76M |
|
208
Spire
SR
$4.74B
| $5.32M | 0.08% |
+109,610
| New | +$5.12M |
|
|
EIGR
209
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $5.31M | 0.08% |
737
-79
| -10% | -$395K |
|
210
Nokia
NOK
$55.1B
| $5.31M | 0.08% |
701,866
+495,638
| +240% | +$3.77M |
|
|
MZOR
211
DELISTED
Mazor Robotics Ltd.
MZOR
| $5.27M | 0.08% |
300,000
| – | – |
|
|
PRA
212
DELISTED
ProAssurance
PRA
| $5.26M | 0.08% |
+118,540
| New | +$5.3M |
|
|
VER
213
DELISTED
VEREIT, Inc.
VER
| $5.24M | 0.08% |
+83,696
| New | +$5.38M |
|
214
Celanese
CE
$5.18B
| $5.23M | 0.08% |
81,393
+37,761
| +87% | +$2.29M |
|
|
CVD
215
DELISTED
COVANCE INC.
CVD
| $5.22M | 0.08% |
+61,027
| New | +$5.44M |
|
|
PXD
216
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.18M | 0.08% |
+22,547
| New | +$4.65M |
|
217
Iron Mountain
IRM
$33.4B
| $5.17M | 0.08% |
157,750
+17,733
| +13% | +$481K |
|
218
NetApp
NTAP
$37.3B
| $5.08M | 0.08% |
138,967
+112,070
| +417% | +$4.02M |
|
219
Quanta Services
PWR
$92.2B
| $5.05M | 0.08% |
+146,144
| New | +$5.06M |
|
|
HUB.B
220
DELISTED
HUBBELL INC CL-B
HUB.B
| $4.99M | 0.08% |
+40,511
| New | +$4.79M |
|
221
Televisa
TV
$1.19B
| $4.88M | 0.08% |
142,091
-92,376
| -39% | -$3.1M |
|
222
CMS Energy
CMS
$20.7B
| $4.82M | 0.07% |
154,606
-192,759
| -55% | -$5.74M |
|
223
CF Industries
CF
$20.5B
| $4.8M | 0.07% |
99,850
+88,325
| +766% | +$4.32M |
|
224
Meta Platforms (Facebook)
META
$1.71T
| $4.76M | 0.07% |
70,743
+14,493
| +26% | +$892K |
|
225
Vertex Pharmaceuticals
VRTX
$130B
| $4.73M | 0.07% |
+50,000
| New | +$3.51M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.